Androgenetic alopecia: Treatment results with topical minoxidil
March 1987
in “Journal of The American Academy of Dermatology”
TLDR Topical minoxidil is a safe and effective treatment for hair loss caused by androgenetic alopecia.
Topical minoxidil is a safe and effective treatment for androgenetic alopecia, according to a study. Both 2% and 3% solutions of minoxidil were found to promote hair regrowth in patients, with an increase in terminal hairs and a decrease in balding area diameter. The study involved 60 subjects with androgenetic alopecia who were treated with topical minoxidil for 12 months. The treatment was well-tolerated with only minor adverse reactions reported and no significant changes in laboratory tests, except for a slight decrease in blood pressure. Long-term trials are needed to determine if the hair growth is sustained with continued therapy.
View this study on jaad.org →
Cited in this study
research Topical minoxidil in early male pattern baldness
Minoxidil promotes hair growth in male pattern baldness.
research Topical Minoxidil Therapy in Hereditary Androgenetic Alopecia
Using minoxidil on the scalp can help grow hair for people with hereditary baldness.
research Alopecia Areata Treated With Topical Minoxidil
Minoxidil can help regrow hair in alopecia areata patients.
Related
research Pustular dermatosis of the scalp due to topical minoxidil 5%
A woman had an unusual allergic reaction to a hair loss treatment, which cleared up after stopping the treatment and using a different medication.
research A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
1% topical minoxidil solution significantly improved hair growth in Japanese women with androgenetic alopecia, with no major side effects.
research Multicenter double blind randomized placebo controlled clinical trial of minoxidil gel in the treatment of alopecia areata
research Alopecia areata treated with topical minoxidil
Topical minoxidil can help hair regrowth in alopecia areata patients, but maintaining the growth after stopping treatment is inconsistent.